Magnitude Biosciences recognised in Developed in Durham as local success story

Magnitude Biosciences was recently featured in Developed in Durham. We were founded as a Durham University spin out in 2018 by life sciences expert Dr. David Weinkove and physicist Dr. Christopher Saunter to bring the benefits of our unique C. elegans approach to industrial drug discovery and commercial industry to improve human and environmental health. Now, in 2021, we are working globally with biotechs, nutrition and consumer goods companies all over the world, but are still proud of our roots in North East England. Read the full Developed in Durham article recognising our success

story here:

https://www.dur.ac.uk/research/news/item/?itemno=44807

To find out how Magnitude Biosciences can support your research contact us via info@magnitudebiosciences.com

Find out more

Press Contact:

Jessica Evans jess@magnitudebiosciences.com

Related Press Releases

Magnitude Biosciences: Revolutionising Research

Contract research organisation Magnitude Biosciences is projecting significant growth as it looks to...Read More

Life Sciences consortium celebrate collective multi-million Biomedical Catalyst 2023 Innovate UK grant

Press Release: 24th July 2023 Photo: From left to right: Prof Carrie Ambler, (LightOx) Dr Sam Whit...Read More

Magnitude Biosciences awarded grant to accelerate the identification of compounds that could slow ageing or treat age-related diseases

Photo: The Magnitude Biosciences Team May 2023, Sedgefield, United Kingdom Magnitude Biosciences Lim...Read More

Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services

Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevit...Read More

Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth

North East UK Biotech Magnitude Biosciences announces new CEO, Fozia Saleem, to accelerate the growt...Read More

SMER28 Extends Healthspan – Revealing a New Target for Ageing Therapeutics

Biotech entrepreneur Ethan Perlstein works with Magnitude Biosciences to reveal a new target for age...Read More

Press Release

Magnitude Biosciences CEO David Weinkove appointed new Chair of British Society for Research on Ageing

The British Society for the Research on Ageing (BSRA) announces its new Chair, biology of ageing res...Read More

Press Release

Magnitude Biosciences, Perfectus Biomed Group and University of Kent Project Funded by National Biofilms Innovation Centre for Tackling and Exploiting Biofilms

The joint project for Magnitude Biosciences, Perfectus Biomed Group and the University of Kent aims ...Read More

Press Release

Research on ageing leader Magnitude Biosciences expands its project delivery team to meet increased demand

Durham, UK – July 29, 2021 Magnitude Biosciences, the world’s leading commercial lab service...Read More

Press Release

Magnitude Biosciences secures its second round of funding to support its pre-clinical research services

Magnitude Biosciences secures its second round of funding to support its pre-clinical research servi...Read More

Press Release

Magnitude Biosciences announces new hires to support continued growth

Durham, UK – March 2021 Magnitude Biosciences, a spin-out from Durham University and the leadi...Read More

Press Release

Magnitude Biosciences secures UK government Future Fund to expand its workforce.

Durham, UK – August 2020 Research into new medicines is needed more than ever, but research la...Read More

Press Release

Magnitude Biosciences’ new COVID-19 compatible laboratory is fully operational and we are ready to support your research

Magnitude Biosciences moves its unique COVID-19 compatibletechnology to a new lab at NETPark in Sedg...Read More

Magnitude Biosciences recognised in Developed in Durham as local success story

Related Press Releases

Get regular updates in your inbox